BioSpace

Lilly Cuts Zepbound Prices, Again, When Buying Through DTC Program

Following Novo Nordisk’s price cuts for its own GLP-1 medicines, Eli Lilly is offering discounts for the obesity drug ...

Lilly Cuts Low-Dose Zepbound Price Up to 20% for Cash-Pay Buyers

Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up ...

Novo's Next Shot at Dominance: High-Dose Wegovy Takes Aim at Lilly's Zepbound

Regulators in Europe just backed Novo's heavyweight Wegovy--setting the stage for a head-to-head obesity drug showdown in ...
Drug Store News

Eli Lilly lowers price of Zepbound single-dose vials

With a valid prescription, patients can access the starting dose of Zepbound single-dose vial (2.5 mg) for as low as $299 per ...
Devdiscourse

Race in Obesity Drugs Heats Up Amidst Legal Battles and Aid Crises

Eli Lilly's new obesity drug shows promising results in weight loss, surpassing its existing drug Zepbound, as competition in ...
Yahoo

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on Thursday, May 8, 2025. (AP Photo/JoNel Aleccia) People taking Eli Lilly's obesity drug, Zepbound, lost ...
Fierce Pharma

Lilly joins Novo in GLP-1 self-pay price cuts, lowering costs of single-dose Zepbound vials

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

GLP-1 drugs have 'little or no effect' on risk of obesity-related cancers, study suggests

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...